- Corporate Officers - A
- Aldrich Richard
Insider Trading History of Aldrich Richard
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Aldrich Richard since 2006.
This trader's CIK number is 1185039.
At the time of last reporting, Aldrich Richard was the Director of Concert Pharmaceuticals, Inc.. (stock ticker symbol CNCE).
Also see all insider trading activities at Concert Pharmaceuticals, Inc..
Note that in the past
ALDRICH RICHARD also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Aradigm Corp (ARDM) by Aldrich Richard
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | ARDM | 0 | $0 | 5,600,000 | $1,400,000 | 0 | $0 |
Yearly summary of insider trading at Kalvista Pharmaceuticals, Inc. (KALV) by Aldrich Richard
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | KALV | 565,065 | $4,866,904 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Sequenom Inc (SQNM) by Aldrich Richard
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | SQNM | 1,042,250 | $14,212,762 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ptc Therapeutics, Inc. (PTCT) by Aldrich Richard
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | PTCT | 0 | $0 | 7,000 | $390,950 | 7,000 | $75,950 |
| 2013 | PTCT | 766,667 | $11,500,005 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Concert Pharmaceuticals, Inc. (CNCE) by Aldrich Richard
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | CNCE | 210,526 | $999,998 | 0 | $0 | 0 | $0 |
| 2018 | CNCE | 50,000 | $594,550 | 121,236 | $2,393,760 | 21,236 | $77,405 |
| 2015 | CNCE | 0 | $0 | 20,000 | $395,200 | 0 | $0 |
Yearly summary of insider trading at Tempest Therapeutics, Inc. (OVAS) by Aldrich Richard
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | OVAS | 962,056 | $7,386,145 | 0 | $0 | 0 | $0 |
| 2015 | OVAS | 2,500 | $74,925 | 0 | $0 | 0 | $0 |
| 2014 | OVAS | 116,000 | $1,131,388 | 0 | $0 | 0 | $0 |
| 2013 | OVAS | 4,850 | $51,118 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Biospecifics Technologies Corp (BSTC) by Aldrich Richard
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | BSTC | 60,865 | $967,276 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Lipid Sciences Inc/ (LIPD) by Aldrich Richard
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | LIPD | 0 | $0 | 100,600 | $147,379 | 0 | $0 |
Yearly summary of insider trading at Verastem, Inc. (VSTM) by Aldrich Richard
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | VSTM | 1,000 | $8,370 | 0 | $0 | 0 | $0 |
| 2013 | VSTM | 20,000 | $270,190 | 0 | $0 | 0 | $0 |
Insider trading activities at 9 companies by Aldrich Richard:
1. Aradigm Corp (ARDM)
2. Kalvista Pharmaceuticals, Inc. (KALV)
3. Sequenom Inc (SQNM)
4. Ptc Therapeutics, Inc. (PTCT)
5. Concert Pharmaceuticals, Inc. (CNCE)
6. Tempest Therapeutics, Inc. (OVAS)
7. Biospecifics Technologies Corp (BSTC)
8. Lipid Sciences Inc/ (LIPD)
9. Verastem, Inc. (VSTM)
Table 1. Insider trading of Aradigm Corp (ARDM) by Aldrich Richard
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-10-29 | ARDM | Sale | 5,600,000 | .25 | 1,400,000 |
Table 2. Insider trading of Kalvista Pharmaceuticals, Inc. (KALV) by Aldrich Richard
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-10-12 | KALV | Buy | 565,065 | 8.61 | 4,866,904 |
Table 3. Insider trading of Sequenom Inc (SQNM) by Aldrich Richard
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-06-25 | SQNM | Buy | 33,417 | 15.02 | 501,956 |
| 2008-06-25 | SQNM | Buy | 25,748 | 14.47 | 372,573 |
| 2008-06-25 | SQNM | Buy | 341,567 | 15.49 | 5,289,506 |
| 2008-06-25 | SQNM | Buy | 19,269 | 16.12 | 310,539 |
| 2008-06-09 | SQNM | Buy | 32,400 | 11.88 | 384,847 |
| 2008-06-06 | SQNM | Buy | 11,600 | 11.74 | 136,242 |
| 2008-06-10 | SQNM | Buy | 183,600 | 12.19 | 2,237,166 |
| 2008-06-09 | SQNM | Buy | 208,119 | 12.93 | 2,691,394 |
| 2008-06-09 | SQNM | Buy | 126,700 | 12.11 | 1,534,083 |
| 2008-06-09 | SQNM | Buy | 59,830 | 12.61 | 754,456 |
Table 4. Insider trading of Ptc Therapeutics, Inc. (PTCT) by Aldrich Richard
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-06-08 | PTCT | Option Ex | 7,000 | 10.85 | 75,950 |
| 2015-06-08 | PTCT | Sale | 7,000 | 55.85 | 390,950 |
| 2013-06-25 | PTCT | Buy | 766,667 | 15.00 | 11,500,005 |
Table 5. Insider trading of Concert Pharmaceuticals, Inc. (CNCE) by Aldrich Richard
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-06-06 | CNCE | Buy | 210,526 | 4.75 | 999,998 |
| 2018-11-15 | CNCE | Buy | 50,000 | 11.89 | 594,550 |
| 2018-02-01 | CNCE | Sale | 1,946 | 19.99 | 38,900 |
| 2018-01-30 | CNCE | Sale | 5,000 | 21.33 | 106,649 |
| 2018-01-31 | CNCE | Sale | 5,000 | 21.04 | 105,175 |
| 2018-01-29 | CNCE | Sale | 5,000 | 21.36 | 106,800 |
| 2018-01-26 | CNCE | Sale | 5,000 | 20.46 | 102,300 |
| 2018-01-25 | CNCE | Sale | 8,054 | 20.27 | 163,214 |
| 2018-01-23 | CNCE | Sale | 10,000 | 19.68 | 196,750 |
| 2018-01-24 | CNCE | Sale | 10,000 | 19.83 | 198,299 |
| 2018-01-22 | CNCE | Sale | 10,000 | 19.55 | 195,450 |
| 2018-01-17 | CNCE | Sale | 10,000 | 18.99 | 189,899 |
| 2018-01-19 | CNCE | Sale | 10,000 | 19.66 | 196,550 |
| 2018-01-18 | CNCE | Sale | 10,000 | 19.39 | 193,950 |
| 2018-01-16 | CNCE | Sale | 31,236 | 19.20 | 599,824 |
| 2018-01-16 | CNCE | Option Ex | 21,236 | 3.65 | 77,405 |
| 2015-12-16 | CNCE | Sale | 20,000 | 19.76 | 395,200 |
Table 6. Insider trading of Tempest Therapeutics, Inc. (OVAS) by Aldrich Richard
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-06-01 | OVAS | Buy | 425,000 | 7.00 | 2,975,000 |
| 2016-05-18 | OVAS | Buy | 20,000 | 7.86 | 157,200 |
| 2016-05-17 | OVAS | Buy | 20,000 | 7.56 | 151,200 |
| 2015-05-16 | OVAS | Buy | 20,000 | 7.69 | 153,800 |
| 2016-05-12 | OVAS | Buy | 19,800 | 6.92 | 137,115 |
| 2016-05-13 | OVAS | Buy | 16,295 | 7.06 | 115,042 |
| 2016-05-11 | OVAS | Buy | 20,000 | 7.64 | 152,800 |
| 2016-05-10 | OVAS | Buy | 19,900 | 7.72 | 153,628 |
| 2016-03-24 | OVAS | Buy | 30,000 | 9.23 | 276,900 |
| 2016-03-23 | OVAS | Buy | 29,800 | 9.88 | 294,453 |
| 2016-03-21 | OVAS | Buy | 30,000 | 10.11 | 303,360 |
| 2016-03-22 | OVAS | Buy | 29,800 | 10.53 | 313,913 |
| 2016-03-17 | OVAS | Buy | 29,800 | 7.79 | 232,231 |
| 2016-03-18 | OVAS | Buy | 29,900 | 8.72 | 260,757 |
| 2016-03-16 | OVAS | Buy | 29,529 | 7.86 | 232,038 |
| 2016-03-15 | OVAS | Buy | 29,500 | 8.12 | 239,628 |
| 2016-03-14 | OVAS | Buy | 30,000 | 8.05 | 241,590 |
| 2016-03-11 | OVAS | Buy | 132,732 | 7.50 | 995,490 |
| 2015-04-08 | OVAS | Buy | 2,500 | 29.97 | 74,925 |
| 2014-07-07 | OVAS | Buy | 2,000 | 9.49 | 18,980 |
| 2014-06-30 | OVAS | Buy | 2,000 | 9.16 | 18,320 |
| 2014-06-23 | OVAS | Buy | 2,000 | 8.81 | 17,628 |
| 2014-06-16 | OVAS | Buy | 2,000 | 8.52 | 17,040 |
| 2014-06-09 | OVAS | Buy | 2,000 | 7.59 | 15,180 |
| 2014-06-02 | OVAS | Buy | 2,000 | 7.29 | 14,580 |
| 2014-05-27 | OVAS | Buy | 2,000 | 7.50 | 15,000 |
| 2014-05-19 | OVAS | Buy | 2,000 | 7.33 | 14,660 |
| 2014-03-07 | OVAS | Buy | 100,000 | 10.00 | 1,000,000 |
| 2013-09-11 | OVAS | Buy | 4,850 | 10.54 | 51,118 |
Table 7. Insider trading of Biospecifics Technologies Corp (BSTC) by Aldrich Richard
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-11-14 | BSTC | Buy | 14,300 | 16.40 | 234,519 |
| 2008-11-13 | BSTC | Buy | 24,165 | 16.29 | 393,647 |
| 2008-11-12 | BSTC | Buy | 10,000 | 15.32 | 153,160 |
| 2008-11-05 | BSTC | Buy | 500 | 16.00 | 8,000 |
| 2008-10-30 | BSTC | Buy | 1,000 | 14.00 | 14,000 |
| 2008-10-31 | BSTC | Buy | 10,000 | 15.00 | 150,000 |
| 2008-11-03 | BSTC | Buy | 900 | 15.50 | 13,950 |
Table 8. Insider trading of Lipid Sciences Inc/ (LIPD) by Aldrich Richard
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-12-21 | LIPD | Sale | 100,600 | 1.47 | 147,379 |
Table 9. Insider trading of Verastem, Inc. (VSTM) by Aldrich Richard
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-05-20 | VSTM | Buy | 1,000 | 8.37 | 8,370 |
| 2013-11-11 | VSTM | Buy | 1,000 | 10.93 | 10,930 |
| 2013-11-04 | VSTM | Buy | 1,000 | 10.51 | 10,510 |
| 2013-10-28 | VSTM | Buy | 1,000 | 11.26 | 11,260 |
| 2013-10-21 | VSTM | Buy | 1,000 | 12.57 | 12,570 |
| 2013-10-14 | VSTM | Buy | 1,000 | 10.56 | 10,560 |
| 2013-10-07 | VSTM | Buy | 1,000 | 11.53 | 11,530 |
| 2013-09-30 | VSTM | Buy | 1,000 | 12.55 | 12,550 |
| 2013-09-23 | VSTM | Buy | 1,000 | 13.17 | 13,170 |
| 2013-09-16 | VSTM | Buy | 1,000 | 13.81 | 13,810 |
| 2013-09-09 | VSTM | Buy | 1,000 | 14.04 | 14,040 |
| 2013-09-03 | VSTM | Buy | 1,000 | 14.07 | 14,070 |
| 2013-08-26 | VSTM | Buy | 1,000 | 14.21 | 14,210 |
| 2013-08-19 | VSTM | Buy | 1,000 | 13.45 | 13,450 |
| 2013-08-12 | VSTM | Buy | 1,000 | 14.75 | 14,750 |
| 2013-08-05 | VSTM | Buy | 1,000 | 15.25 | 15,250 |
| 2013-07-29 | VSTM | Buy | 1,000 | 15.15 | 15,150 |
| 2013-07-24 | VSTM | Buy | 1,000 | 16.39 | 16,390 |
| 2013-07-15 | VSTM | Buy | 1,000 | 17.19 | 17,190 |
| 2013-07-08 | VSTM | Buy | 1,000 | 14.69 | 14,690 |
| 2013-07-01 | VSTM | Buy | 1,000 | 14.11 | 14,110 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Aldrich Richard
(Director of Concert Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.